Semaglutide, Other GLP-1 Receptor Agonists, and Papillary Thyroid Carcinoma: A Narrative Review of Risk, Progression, and Mechanisms
Journal of clinical medicine · 2026 Oct 11 · Barseghyan L, Munir I, Chrysafide S et
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 10 20:00 ETSource: Journal of clinical medicine
From the source
Read at pubmed.ncbi.nlm.nih.govSemaglutide, Other GLP-1 Receptor Agonists, and Papillary Thyroid Carcinoma: A Narrative Review of Risk, Progression, and Mechanisms
Journal of clinical medicine · 2026 Oct 11 · Barseghyan L, Munir I, Chrysafide S et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42941350/
